Consensus Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 21:00:02 06/09/2024 BST			5-day change	1st Jan Change
902.71 ^USD	-1.10%		-5.97%	+54.86%

09-06	Are thematic ETFs useless?
09-06	Veeva Systems: leader in cloud solutions for the life sciences industry

Evolution of the Average Target: Eli Lilly and Company

Evolution of the Target Price: Eli Lilly and Company

Changes in Analyst Recommendations: Eli Lilly and Company

071e5fd614edefee61ad8e18abfca9.XWgGlBgTJvfzS5GminDx-rls_GJS3sOitl6reSFATs8.LiRQ528hErCZeOHhuRKdr-YZjTMNmvHEhRzNAE8iIpkqWlP6WWN5gqkcqQ~42cd8c60da6b547da5baca7e121befc4

Analysts' recommendations: Eli Lilly and Company

Jefferies Adjusts Price Target on Eli Lilly to $1,113 From $1,050	08-27	MT
Global markets live: Novo Nordisk, Walmart, Target, Keysight Technologies, Coty...	08-21
Eli Lilly: risk of diabetes reduced by 94% with tirzepatide	08-20	CF
HSBC Adjusts Price Target on Eli Lilly and Co. to $1,150 From $1,100, Maintains Buy Rating	08-15	MT
ELI LILLY : Berenberg raises its price target	08-14	CF
Eli Lilly: share price rises, Berenberg raises target	08-14	CF
Daiwa Securities Adjusts Price Target on Eli Lilly and Co. to $940 From $800, Maintains Outperform Rating	08-14	MT
Berenberg Adjusts Price Target on Eli Lilly and Co. to $1,050 From $1,000, Maintains Buy Rating	08-14	MT
Deutsche Bank Upgrades Eli Lilly to Buy From Hold, Raises Price Target to $1,025 From $725	08-12	MT
Analyst recommendations: Biogen, Cloudflare, Doordash, Moderna, Diageo...	08-12
Redburn Atlantic Adjusts Eli Lilly Price Target to $640 From $600	08-09	MT
Wells Fargo Adjusts Price Target on Eli Lilly to $1,000 From $875, Maintains Overweight Rating	08-09	MT
JPMorgan Adjusts Price Target on Eli Lilly and Company to $1,050 From $1,000, Maintains Overweight Rating	08-09	MT
BMO Capital Adjusts Price Target on Eli Lilly to $1,101 From $1,001, Maintains Outperform Rating	08-09	MT
Leerink Partners Adjusts Eli Lilly Price Target to $990 From $901	08-09	MT
Morgan Stanley Raises Price Target on Eli Lilly to $1,106 From $1,083, Adds 'Top Pick' Label, Keeps Overweight Rating	08-09	MT
Guggenheim Adjusts Price Target on Eli Lilly to $884 From $855	08-05	MT
Wolfe Research Adjusts Eli Lilly's Price Target to $1,117 From $909	07-24	MT
Analyst recommendations: Colgate, Lockheed Martin, Procter & Gamble, Eli Lilly, Tesla...	07-24
HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating	07-19	MT
Analyst recommendations: Bank of America, Pepsico, Apple, Chewy, Eli Lilly...	07-19
TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	07-17	MT
Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...	07-17
Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793	07-16	MT
UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating	07-12	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	ELI LILLY AND COMPANY					+9.32%
	NOVO NORDISK A/S					+9.99%
	JOHNSON & JOHNSON					+3.83%
	ABBVIE INC.					+1.50%
	MERCK & CO., INC.					+18.14%
	ROCHE HOLDING AG					+8.68%
	ASTRAZENECA PLC					+10.49%
	NOVARTIS AG					-0.25%
	AMGEN INC.					+1.37%
	PFIZER, INC.					+16.36%
	Average					+7.94%
	Weighted average by Cap.					+8.13%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

902.71USD

Average target price

986.82USD

Spread / Average Target

+9.32%

High Price Target

1,150.00USD

Spread / Highest target

+27.39%

Low Price Target

580.00USD

Spread / Lowest Target

-35.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
Goldman Sachs
Argus
Redburn Atlantic
China International Capital
JPMorgan Chase
Wolfe Research
Barclays
BMO Capital
Leerink Partners
Deutsche Bank Securities
Truist Securities
Wells Fargo Securities
Morgan Stanley
UBS
BofA Securities
DZ Bank
JEFFERIES	Akash Tewari
Cantor Fitzgerald
Morningstar
Guggenheim
Daiwa Securities
Berenberg Bank
Citigroup
Credit Suisse
HSBC
TD Cowen
SVB Securities LLC
Cowen
Mizuho Securities